Using Patient Feedback to Optimize the Design of a Certolizumab Pegol Electromechanical Self-Injection Device: Insights from Human Factors Studies
ConclusionCZP e-Device development was guided by intended user feedback through HFS, ensuring the final design addressed patients ’ needs. In both validation studies, participants successfully performed all critical tasks, demonstrating safe and effective e-Device self-injections.FundingUCB Pharma.Plain Language SummaryPlain language summary available on the journal website.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Ankylosing Spondylitis | Arthritis | Crohn's Disease | Drugs & Pharmacology | Pharmaceuticals | Psoriatic Arthritis | Rheumatoid Arthritis | Rheumatology | Study | Websites